Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma
Authors
- Kai Wille (ORCID: https://orcid.org/0000-0002-7682-8563)
- Niklas Gebauer (ORCID: https://orcid.org/0000-0003-0566-4554)
- Semra Aydin (ORCID: https://orcid.org/0000-0001-7393-9690)
- Paulina Maria Nierychlewska
- Akhil Behringer
- Giuliano Filippini Velázquez (ORCID: https://orcid.org/0000-0003-2884-3432)
- Christoph Kimmich
- Marcel Teichert
- Philipp Berning (ORCID: https://orcid.org/0000-0003-0442-3521)
- Ulf Schnetzke (ORCID: https://orcid.org/0000-0001-7455-8988)
- Susanne Ghandili (ORCID: https://orcid.org/0000-0001-5655-3155)
- Alexander Sebastian Hölscher (ORCID: https://orcid.org/0009-0004-8994-1137)
- Joseph Kauer (ORCID: https://orcid.org/0000-0003-1632-0167)
- Vanja Zeremski (ORCID: https://orcid.org/0000-0002-5254-9885)
- Vadim Lesan (ORCID: https://orcid.org/0000-0002-2600-2122)
- Isabelle Krämer (ORCID: https://orcid.org/0000-0003-1667-4109)
- U. Vehling-Kaiser
- Philipp Gödel (ORCID: https://orcid.org/0000-0001-7887-8313)
- Bjoern Chapuy (ORCID: https://orcid.org/0000-0002-6485-8773)
- Florian Kaiser (ORCID: https://orcid.org/0000-0002-5844-1779)
- Julia Katharina Scholz
- Hristo Boyadzhiev
- Thomas Melchardt (ORCID: https://orcid.org/0000-0002-0122-3631)
- Mareike Tometten
- Karin Mayer (ORCID: https://orcid.org/0000-0001-7223-9748)
- Andrea Kerkhoff (ORCID: https://orcid.org/0000-0001-6904-2821)
- Chiara Wirths
- Sebastian Scheich (ORCID: https://orcid.org/0000-0001-6408-3536)
- Evgenii Shumilov (ORCID: https://orcid.org/0000-0003-0178-1729)
- Mathias Lutz (ORCID: https://orcid.org/0000-0002-2572-5687)
- Ulrike Bacher
- C. Schultze-Florey
- Martin Bentz
- Christiane Pott (ORCID: https://orcid.org/0009-0005-9260-8340)
- E. Shorb
- Rebecca Wurm-Kuczera
- U. Holtick
- Paolo Mazzeo
- Florian Heidel
- Peter Dreger
- Anna Ossami-Saidy
- Francis Ayuk
- Thomas Pabst
- Lorenz Thurner
- Bastian von Tresckow
- Meng Wang
- Sascha Dietrich
- Bertram Glass
- Christian W. Scholz
- Henriette Huber
- Mathias Hänel
- Thomas Oellerich
- Enrico Derenzini
- Dimitrios Mougiakakos
- Fabian Müller
- Vladan Vucinic
- Georg Lenz
- Philipp Nakov
Institutions
- Goethe University Frankfurt (DE)
- Universität Hamburg (DE)
- University of Freiburg (DE)
- University of Applied Sciences Landshut (DE)
- Heidelberg University (DE)
- Paracelsus Medical University (AT)
- University Hospital Bonn (DE)
- University Hospital of Bern (CH)
- University Medical Center Freiburg (DE)
- University Hospital Augsburg (DE)
- University Hospital Heidelberg (DE)
- University Hospital of Basel (CH)
- University Medical Center (US)
- Medizinische Hochschule Hannover (DE)
- Humboldt-Universität zu Berlin (DE)
- Universitätsklinikum Erlangen (DE)
- Düsseldorf University Hospital (DE)
- University Hospital Münster (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Klinikum Oldenburg (DE)
- Vivantes Klinikum (DE)
- University Hospital Schleswig-Holstein (DE)
- Nephrologisches Zentrum Goettingen (DE)
- Essen University Hospital (DE)
- University Hospital Leipzig (DE)
- Pius Hospital Oldenburg (DE)
- University Hospital Frankfurt (DE)
- Jena University Hospital (DE)
- University Hospital Magdeburg (DE)
- University Hospital Cologne (DE)
- Helios Hospital Berlin-Buch (DE)
- West German Heart and Vascular Center Essen (DE)
- Klinikum Chemnitz (DE)
- Johannes Wesling Klinikum Minden (DE)
- Heinrich Heine University Düsseldorf (DE)
- European Institute of Oncology (IT)
- RWTH Aachen University (DE)
- Saarland University (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Haematologica
- Published
- 2026-04-02
- DOI
- https://doi.org/10.3324/haematol.2025.300063
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- AstraZeneca
- Celgene
- BeiGene
- Incyte
- Swedish Orphan Biovitrum